Your browser is no longer supported. Please, upgrade your browser.
MMSI Merit Medical Systems, Inc. daily Stock Chart
Merit Medical Systems, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own0.10% Shs Outstand55.51M Perf Week0.22%
Market Cap3.06B Forward P/E29.79 EPS next Y1.84 Insider Trans-18.51% Shs Float53.76M Perf Month10.49%
Income-29.40M PEG- EPS next Q0.43 Inst Own- Short Float6.98% Perf Quarter10.60%
Sales963.80M P/S3.17 EPS this Y-88.40% Inst Trans-2.76% Short Ratio8.99 Perf Half Y24.80%
Book/sh16.82 P/B3.26 EPS next Y18.37% ROA-1.70% Target Price61.00 Perf Year96.11%
Cash/sh0.80 P/C68.53 EPS next 5Y11.50% ROE-3.10% 52W Range25.18 - 56.11 Perf YTD75.85%
Dividend- P/FCF30.69 EPS past 5Y-28.80% ROI1.30% 52W High-2.16% Beta1.22
Dividend %- Quick Ratio1.20 Sales past 5Y14.30% Gross Margin41.70% 52W Low118.03% ATR1.90
Employees6355 Current Ratio2.30 Sales Q/Q0.40% Oper. Margin-2.20% RSI (14)67.34 Volatility2.95% 3.58%
OptionableYes Debt/Eq0.38 EPS Q/Q12.00% Profit Margin-3.10% Rel Volume0.70 Prev Close54.50
ShortableYes LT Debt/Eq0.37 EarningsOct 28 AMC Payout- Avg Volume417.46K Price54.90
Recom2.00 SMA204.47% SMA5012.58% SMA20027.59% Volume291,649 Change0.73%
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Sep-10-19Downgrade Raymond James Outperform → Mkt Perform
Jul-26-19Downgrade Wells Fargo Outperform → Market Perform
Jul-26-19Downgrade Needham Buy → Hold
Oct-02-18Reiterated Needham Buy $67 → $73
Aug-07-18Downgrade BofA/Merrill Buy → Underperform
Jul-24-18Reiterated Needham Buy $54 → $67
Jun-01-18Reiterated Needham Buy $54
May-18-18Reiterated SunTrust Buy $55 → $62
Apr-26-18Reiterated Needham Buy $53 → $54
Apr-20-18Initiated Needham Buy $53
Mar-01-18Upgrade Barrington Research Mkt Perform → Outperform $50
Aug-28-17Downgrade Raymond James Strong Buy → Outperform
Jul-20-17Initiated BofA/Merrill Buy $44
Jun-20-17Initiated SunTrust Buy $43
Apr-05-17Initiated Wells Fargo Outperform
Nov-30-20 11:19AM  
Nov-27-20 11:40AM  
Nov-26-20 09:15AM  
Nov-17-20 06:57AM  
Nov-13-20 12:45PM  
Nov-10-20 04:05PM  
Nov-04-20 09:22AM  
Nov-03-20 07:14AM  
Nov-02-20 12:00PM  
Oct-30-20 09:15AM  
Oct-29-20 01:30AM  
Oct-28-20 06:15PM  
Oct-21-20 12:32PM  
Oct-13-20 04:05PM  
Oct-09-20 09:25AM  
Oct-08-20 09:37AM  
Sep-08-20 11:34AM  
Sep-02-20 05:30PM  
Aug-28-20 11:31AM  
Aug-24-20 12:40PM  
Aug-11-20 11:40AM  
Aug-06-20 04:05PM  
Aug-04-20 10:37AM  
Jul-30-20 09:21AM  
Jul-29-20 06:45PM  
Jul-28-20 05:29PM  
Jul-27-20 03:00AM  
Jul-22-20 12:32PM  
Jul-17-20 09:25AM  
Jul-16-20 12:32PM  
Jul-15-20 09:25AM  
Jul-05-20 04:05PM  
Jun-11-20 11:11AM  
Jun-06-20 09:00AM  
May-29-20 09:28PM  
May-26-20 04:01PM  
May-23-20 11:30AM  
May-20-20 04:15AM  
May-19-20 07:15AM  
May-07-20 07:13PM  
Apr-25-20 10:00PM  
Apr-24-20 10:06AM  
Apr-23-20 05:55PM  
Apr-20-20 04:20PM  
Apr-19-20 02:37PM  
Apr-18-20 11:09AM  
Apr-16-20 12:31PM  
Apr-14-20 06:32PM  
Apr-13-20 09:42AM  
Apr-09-20 11:40AM  
Apr-07-20 07:15AM  
Apr-06-20 09:25AM  
Apr-03-20 05:38PM  
Mar-25-20 03:22PM  
Mar-24-20 09:55AM  
Mar-20-20 11:40AM  
Mar-18-20 10:30AM  
Mar-17-20 07:50AM  
Mar-10-20 02:24PM  
Mar-04-20 01:36AM  
Mar-02-20 09:25AM  
Feb-25-20 03:10PM  
Feb-24-20 05:55PM  
Feb-20-20 09:25AM  
Feb-18-20 04:01PM  
Feb-17-20 12:30PM  
Feb-13-20 09:25AM  
Feb-12-20 11:40AM  
Feb-03-20 07:55PM  
Feb-02-20 10:50PM  
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, interventional fluid management, pressure monitoring, and cardiac rhythm management, as well as thermodilution and pulmonary artery catheters and electrophysiology to treat various heart conditions. It also offers cardiovascular and critical care products to treat patients with life-threatening diseases, and protect healthcare providers from exposure to bloodborne pathogens. In addition, it provides interventional oncology and spine products to treat vertebral compression fractures, metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, it offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; microelectromechanical system sensor components; ConvertX nephroureteral stent system; and Fibrovein, a detergent-based sclerosant. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was founded in 1987 and is headquartered in South Jordan, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Floyd DavidDirectorAug 04Buy43.111,15949,9671,584Aug 06 03:25 PM
LIU DAVID MING-TEHDirectorJun 01Option Exercise28.6113,800394,77313,800Jun 03 05:28 PM
LIU DAVID MING-TEHDirectorJun 01Sale45.0013,800621,0000Jun 03 05:28 PM
Karras Nolan E.DirectorMay 28Option Exercise13.995,00069,95015,500May 29 03:46 PM
Karras Nolan E.DirectorMay 28Sale43.875,000219,35010,500May 29 03:46 PM
Karras Nolan E.DirectorMay 27Option Exercise13.995,00069,95015,500May 29 03:46 PM
Karras Nolan E.DirectorMay 27Sale44.125,000220,60010,500May 29 03:46 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMay 20Option Exercise12.065,00060,3006,269May 22 06:25 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMay 20Sale44.005,000220,0001,269May 22 06:25 PM
Wright JosephPRESIDENT, INTERNATIONALMar 13Option Exercise13.1410,000131,40010,000Mar 17 01:09 PM
Miller Franklin JDirectorMar 12Option Exercise9.952,66926,55732,566Mar 13 05:00 PM
Miller Franklin JDirectorMar 11Option Exercise9.952,33123,1934,665Mar 13 05:00 PM
Miller Franklin JDirectorMar 11Sale35.252,33182,1682,334Mar 13 05:00 PM
ANDERSON A SCOTTDirectorMar 06Option Exercise12.9319,000245,61025,400Mar 10 05:51 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMar 06Option Exercise14.67100,0001,466,5001,029,991Mar 10 09:32 PM
ANDERSON A SCOTTDirectorMar 06Sale37.296,638247,53118,762Mar 10 05:51 PM
Miller Franklin JDirectorMar 04Option Exercise9.9515,000149,25017,334Mar 06 09:10 PM
Miller Franklin JDirectorMar 04Sale38.0715,000571,0502,334Mar 06 09:10 PM
Karras Nolan E.DirectorMar 02Option Exercise9.958,00079,60016,000Mar 03 05:26 PM
Karras Nolan E.DirectorMar 02Sale36.695,500201,79510,500Mar 03 05:26 PM